CG Oncology, Inc. - 10-Q Filing
CG Oncology filed its Q1 2026 10-Q report with the SEC on May 6, 2026. As of March 31, 2026, it reported $33.7 million in cash and equivalents, up from $32.5 million as of December 31, 2025. The company held marketable securities valued at $1.04 billion compared to $709.7 million previously.
Tickers: $CGON